Z. Wu

发表

Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men.

S. Anderson, M. Bidlingmaier, C. Strasburger, 2002, The Journal of clinical endocrinology and metabolism.

Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors.

M. Bidlingmaier, C. Strasburger, R. Ross, 2001, Endocrinology.

Problems with GH doping in sports

M. Bidlingmaier, C. Strasburger, Z. Wu, 2003, Journal of endocrinological investigation.

Hypoglycemic action of a novel constrained analog of human growth hormone-(6-13).

M. Hearn, N. Ede, Z. Wu, 1992, Endocrinology.

Monoclonal anti-acid-labile subunit oligopeptide antibodies and their use in a two-site immunoassay for ALS measurement in humans.

C. Strasburger, Zida Wu, R. Dressendörfer, 2001, Journal of immunological methods.

Both fasting‐induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity

S. Grottoli, E. Ghigo, Zida Wu, 2003, Clinical endocrinology.

Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors.

M. Bidlingmaier, C. Strasburger, Zida Wu, 2001, Endocrinology.

Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.

S. Anderson, M. Bidlingmaier, C. Strasburger, 2001, The Journal of clinical endocrinology and metabolism.

Findings and theoretical considerations on the usefulness of the acid-labile subunit in the monitoring of acromegaly.

M. Bidlingmaier, C. Strasburger, K. Morrison, 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

hGH-abuse in athletes.

M. Bidlingmaier, C. Strasburger, Z. Wu, 2007, Annales d'Endocrinologie.

Doping with Growth Hormone

M. Bidlingmaier, C. Strasburger, Zida Wu, 2001, Journal of pediatric endocrinology & metabolism : JPEM.

Association between the GH receptor/exon 3 genotype and the level of exon 3-positive GH-binding protein in human serum.

J. Kratzsch, W. Kiess, C. Strasburger, 2003, European journal of endocrinology.

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Growth Hormone (GH) Receptor Blockade with a PEG- Modified GH (B2036-PEG) Lowers Serum Insulin-Like Growth Factor-I but Does Not Acutely Stimula

M. Straume, M. Bidlingmaier, M. Thorner, 1998 .

The role of human growth hormone's C-terminal disulfide bridge.

C. Strasburger, Z. Wu, R. Junnila, 2013, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA.

J. Verbalis, Wei Zheng, K. Sandberg, 1999, Endocrinology.

The exon 3‐retaining and the exon 3‐deleted forms of the growth hormone‐binding protein (GHBP) in human serum are regulated differently

J. Kratzsch, W. Kiess, B. Dehmel, 2001, Clinical endocrinology.

Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement.

C. Strasburger, R. Dressendörfer, C. Pflaum, 1996, The Journal of clinical endocrinology and metabolism.

Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency

S. Grottoli, E. Ghigo, C. Strasburger, 2001, International Journal of Obesity.

Test method: GH.

M. Bidlingmaier, Z. Wu, C. Strasburger, 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.